Genaera Obtains $24.5 Million in Securities Placement Agreem

To list your company's press release on our NewsWire, send your press release to marketing@perfectdisplay.com.

September 14th, 2005

Genaera Obtains $24.5 Million in Securities Placement Agreements

Genaera Corporation (NASDAQ:GENR) has signed securities purchase agreements valued at $24.5 million. Genaera Corporation is developing products for the treatment of eye, cancer and respiratory problems. These include an eye treatment for wet age-related macular degeneration and a treatment related to the genetic cause of asthma.

Copyright 2004, 2005, Mark C. Stansberry, All Rights Reserved

TERMS OF USE

The publisher of this web site does not certify that the information contained on this web site is 100 percent accurate. Use of this web site requires that the reader release the publisher from all liability that may result from the reliance of information on this web site. The publisher suggests that readers verify any information contained on this web site with three or more other reference sources, as well as directly with any company(s) mentioned. Please report any errors or omissions to marketing@perfectdisplay.com.

The site may include words, or phrases that are specific trademarks of companies mentioned.